Ziopharm Oncology to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 5
February 25 2019 - 7:50AM
Ziopharm Oncology, Inc. (Nasdaq:ZIOP) today announced that
management will host a conference call and webcast slide
presentation on Tuesday, March 5, at 4:30 p.m. ET to provide a
corporate update and discuss financial results for the fourth
quarter and year ended Dec. 31, 2018.
The call can be accessed by dialing
1-844-309-0618 (U.S. and Canada) or 1-661-378-9465 (international).
The passcode for the conference call is 3091306. To access the
slides and live webcast or the subsequent archived recording, visit
the "Investors & Media" section of the Ziopharm website
at www.ziopharm.com. The webcast will be recorded and
available for replay on the Company's website for two weeks.
About Ziopharm Oncology, Inc.
Ziopharm Oncology is an immuno-oncology company focused on
developing end-to-end cost-effective solutions using its non-viral
Sleeping Beauty platform for TCR and CAR T-cell therapies and
immune-stimulating gene therapy with Controlled interleukin 12
(IL-12). The Sleeping Beauty platform genetically modifies T cells
with DNA plasmids to express T-cell receptors (TCRs) to target
specific antigens in solid tumors and chimeric antigen receptors
(CARs) to target CD19 in blood cancers with the Company’s very
rapid T-cell manufacturing process. The Sleeping Beauty platform is
being advanced in collaboration with the National Cancer Institute,
The University of Texas MD Anderson Cancer Center and Eden BioCell.
The Company also is developing its Controlled IL-12 platform or
Ad-RTS-hIL-12 plus veledimex as monotherapy and in combination with
immune checkpoint inhibitors to treat brain cancer, including in
collaboration with Regeneron Pharmaceuticals.
Company contacts: David Connolly Vice President,
Corporate Communications and Investor Relations 617-502-1881
dconnolly@ziopharm.com
Mike MoyerVice President, Portfolio
Strategy617-765-3770mmoyer@ziopharm.com
ZIOPHARM Oncology (NASDAQ:ZIOP)
Historical Stock Chart
From Mar 2024 to Apr 2024
ZIOPHARM Oncology (NASDAQ:ZIOP)
Historical Stock Chart
From Apr 2023 to Apr 2024